Protective effects of the Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear factor-κB ligand expression in rabbits with knee osteoarthritis

Chen,Sainan; Huang,Yunmei; Chen,Wenlie; Wu,Guangwen; Liao,Naishun; Li,Xihai; Huang,Meiya; Lin,Ruhui; Yu,Chao; Li,Xiaodong; Liu,Xianxiang

doi:10.3892/mmr.2015.4547

Protective effects of the Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear factor-κB ligand expression in rabbits with knee osteoarthritis

Authors:
- Sainan Chen
- Yunmei Huang
- Wenlie Chen
- Guangwen Wu
- Naishun Liao
- Xihai Li
- Meiya Huang
- Ruhui Lin
- Chao Yu
- Xiaodong Li
- Xianxiang Liu
View Affiliations

Affiliations: Fujian Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China, National Laboratory of Traditional Chinese Medicine Pharmacology (Cell Structure and Function), Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China
Published online on: November 11, 2015 https://doi.org/10.3892/mmr.2015.4547
Pages: 419-425

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The imbalance of subchondral bone remodeling is a common pathological feature in the progression of osteoarthritis. In the current study, using a rabbit model of knee osteoarthritis, the effects of the Tougu Xiaotong capsule (TGXTC) on the cartilage and subchondral bone were investigated. In addition, osteoprotegerin (OPG), an inducer of bone formation, and receptor activator of nuclear factor‑κB ligand (RANKL), a regulator of bone resorption in the subchondral bone, were assessed, in order to further explore the protective role of TGXTC in subchondral bone remodeling. The rabbit model of knee osteoarthritis, which was induced by a modified version of Hulth's method, was treated with TGXTC or glucosamine hydrochloride for 4 or 8 weeks. Subsequently, the tibia and femur were harvested for observation of cartilage histology, and the subchondral bone was observed by scanning electron microscopy. The expression levels of OPG and RANKL at the gene and protein levels were determined by reverse transcription‑quantitative polymerase chain reaction and western blotting. TGXTC and glucosamine hydrochloride were identified to mitigate cartilage injury, reduce trabecular number and thickness and accelerate trabecular separation. It was additionally observed that the level of OPG mRNA and protein expression was reduced, and the RANKL mRNA and protein expression level was increased, in addition to the observation of a lower OPG/RANKL ratio in the TGXTC and hydrochloride groups. Taken together, these results suggest that TGXTC may mitigate cartilage injury and subchondral sclerosis, thus delaying the pathological development of osteoarthritis. This is suggested to be mediated partly through the reduction of OPG expression and increase of RANKL expression, which reduces the OPG/RANKL ratio, suppressing excessive bone formation.

View Figures

View References

1	Englund M, Guermazi A, Gale D, Hunter DJ, Aliabadi P, Clancy M and Felson DT: Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med. 359:1108–1115. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hunter DJ: Osteoarthritis. Best Pract Res Clin Rheumatol. 25:801–814. 2011. View Article : Google Scholar
3	Radin EL and Rose RM: Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res. 213:34–40. 1986.PubMed/NCBI
4	Orth P, Cucchiarini M, Kaul G, Ong MF, Gräber S, Kohn DM and Madry H: Temporal and spatial migration pattern of the subchondral bone plate in a rabbit osteochondral defect model. Osteoarthritis Cartilage. 20:1161–1169. 2012. View Article : Google Scholar : PubMed/NCBI
5	Bünger MH, Birkbak M, Pedersen JS, et al: Effect of bisphosphonate treatment on subchondral bone nanostructure in the dunkin hartley guinea pig model of osteoarthritis studied by scanning small-angle X-ray scattering. Bone. 50(S1): S1172012. View Article : Google Scholar
6	Hudelmaier M, Wirth W, Nevitt M, et al: Longitudinal rates of change in subchondral bone size in healthy knees and knees with radiographic osteoarthritis. Osteoarthritis Cartilage. 21:S2422013. View Article : Google Scholar
7	Boyce BF and Xing L: Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
8	Trouvin AP and Goëb V: Receptor activator of nuclear factor-κB ligand and osteoprotegerin: Maintaining the balance to prevent bone loss. Clin Interv Aging. 5:345–354. 2010.
9	Tanaka H, Mine T, Ogasa H, Taguchi T and Liang CT: Expression of RANKL/OPG during bone remodeling in vivo. Biochem Biophys Res Commun. 411:690–694. 2011. View Article : Google Scholar : PubMed/NCBI
10	Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, Shahane A, Quan H, Bolognese J and Mortensen E: Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group. Arthritis Rheum. 43:370–377. 2000. View Article : Google Scholar : PubMed/NCBI
11	Zheng C, Ye H, Xu X and Liu XX: Computational pharmacology study of tougu xiaotong granule in preventing and treating knee osteoarthritis. Chin J Integr Med. 15:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
12	Lin MN and Liu XX: Tougu Xiaotong decoction for treating 30 cases of osteoarthritis of the knee. Fujian J Tradit Chin Med. 36:15–16. 2005.In Chinese.
13	Li XH, Wu MX, Ye HZ, Chen WL, Lin JM, Zheng LP and Liu XX: Experimental study on the suppression of sodium nitroprussiate-induced chondrocyte apoptosis by Tougu Xiaotong Capsule (透骨消痛胶囊)-containing serum. Chin J Integr Med. 17:436–443. 2011. View Article : Google Scholar : PubMed/NCBI
14	Wu ZL, Li XH, Wu GW, Ye HZ, WU MX and Liu XX: Effect of drug-containing serum of Tougu Xiaotong Capsule to apoptotic pathway of chondrocyte mitochondria. Chin J Tradit Chin Med. 26:343–346. 2011.
15	Li X, Lang W, Ye H, Yu F, Li H, Chen J, Cai L, Chen W, Lin R, Huang Y, et al: Tougu Xiaotong capsule inhibits the tidemark replication and cartilage degradation of papain-induced osteoarthritis by the regulation of chondrocyte autophagy. Int J Mol Med. 31:1349–1356. 2013.PubMed/NCBI
16	Ye HZ, Li XH, Chen JS, Zheng CS, Yang JP, Wong XP, Zeng ZP, Zheng Z and Liu XX: Study on the effect of Tougu Xiaotong capsule medicated serum on the expression of cyclin D1 mRNA in chondrocytes. J Tradit Chin Orthopedic Traumatol. 24:3–7. 2012.In Chinese.
17	Huang YM, Chen WL, Liu XX, Huang MY, Lin RH, Li Min, Xiao CY and Wu GW: Histochemical study of osteoarthritis treated by Tougu Xiaotong granule. Chin J Tradit Med Traumatol Orthop. 19:1–3. 2011.In Chinese.
18	Liu BL, Zou JL, Liang GQ, Liu XX, Li XH and Wu GW: Regulatory effects of Tougu Xiaotong granule on wnt/β-catenin signal pathway of articular chondrocytes. Chin J Tissue Eng Res. 15:8574–8578. 2011.In Chinese.
19	Liu BL, Liang GQ, Liu XX, Wu GW and Li XH: Expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary knee osteoarthritis interfered by Tougu Xiaotong granules. Chin J Tissue Eng Res Clinic Rehabilit. 15:2034–2037. 2011.In Chinese.
20	Chen Y, Xiao XJ, Bao XP, et al: Analgesia and anti-inflammatory effects of Tougu Xiaotong prescription. China J Chin Med. 28:1675–1676. 2013.In Chinese.
21	Huang YM, Chen WL, Lin RH, Huang MY, Li ZF, Liao NS and Liu XX: Tougu Xiaotong capsule promotes the proliferation and differentiation of osteoblasts. Chinese J Tissue Eng Res. 17:5923–5928. 2013.In Chinese.
22	Guidance Suggestions for the Care and Use of Laboratory Animals. The Ministry of Science and Technology of the People's Republic of China; Beijing, China: pp. 1–5. 2006, In Chinese.
23	Liu XX, Li XH and Zhou JT: Experimental study on replicating knee osteoarthritis by modified Hulth's modeling method. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:1004–1008. 2005.In Chinese.
24	Kuettner KE and Cole AA: Cartilage degeneration in different human joints. Osteoarthritis Cartilage. 13:93–103. 2005. View Article : Google Scholar : PubMed/NCBI
25	Cox LG, van Donkelaar CC, van Rietbergen B, Emans PJ and Ito K: Decreased bone tissue mineralization can partly explain subchondral sclerosis observed in osteoarthritis. Bone. 50:1152–1161. 2013. View Article : Google Scholar
26	Zhu S, Chen K, Lan Y, Zhang N, Jiang R and Hu J: Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats. Bone. 53:340–349. 2013. View Article : Google Scholar : PubMed/NCBI
27	Kearns AE, Khosla S and Kostenuik PJ: Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev. 29:155–192. 2008. View Article : Google Scholar
28	Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH and Mumm S: Osteoprotegerin deficiency and Juvenile Paget's disease. N Engl Med. 347:175–184. 2002. View Article : Google Scholar
29	Trouvin AP and Goëb V: Receptor activator of nuclear factor-κB ligand and osteoprotegerin: Maintaining the balance to prevent bone loss. Clin Interv Aging. 5:345–354. 2010.
30	Brzóska MM and Rogalska J: Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats. Toxicol Appl Pharmacol. 272:208–220. 2013. View Article : Google Scholar : PubMed/NCBI
31	Maddi A, Hai H, Ong ST, Sharp L, Harris M and Meghji S: Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like Cells. Bone. 39:283–288. 2006. View Article : Google Scholar : PubMed/NCBI